Hahn Laboratory

About the Lab

The Hahn Laboratory’s focus is understanding the impact of antimicrobial pharmacokinetics and pharmacodynamics (PK/PD) during treatment of pulmonary exacerbations in persons with cystic fibrosis, specifically on changes within the airway microbiome. We are studying microbial taxonomic diversity and functional diversity, including the impact of antimicrobial resistance. Our work published to date has revealed beta-lactam PK/PD to be an important contributor to recovery of microbial diversity after antibiotic treatment.
  • Lab Focus Areas

    Cystic Fibrosis 
    Antimicrobial Pharmacokinetics 
    Airway Microbiome 
    Antibiotic Resistance

  • Partnerships

    George Washington University Milken Institute School of Public Health
    Computational Biology Institute at George Washington University

  • Contact

    Andrea Hahn, M.D., M.S. Principal Investigator 202-476-3340